Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Importance of analyzing the impact of life stressors on those with MS

A Michigan Medicine-led study finds that stressors across the lifespan -; including poverty, abuse and divorce -; are associated with worsening health and functional outcomes for people with multiple sclerosis.

25 May 2023

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Epstein-Barr virus (EBV) has a significant role in the development of multiple sclerosis (MS), with evidence linking EBV infection to increased MS risk and immune dysregulation. Understanding the mechanisms underlying this connection is crucial for advancing MS therapies and prevention strategies.

24 May 2023

Cross-reactivity between Epstein-Barr virus and protein in multiple sclerosis sheds light on disease development

Research uncovers the association between multiple sclerosis (MS) and antibody reactivity to specific amino acids in CRYAB, along with the increased risk when combined with high EBNA1 responses. The study provides evidence of antibody and T cell cross-reactivity between EBNA1 and CRYAB, highlighting the role of EBV adaptive immune responses in MS development.

21 May 2023

Whole body cryostimulation: Useful "add-on" treatment for obesity

Whole body cryostimulation is a useful "add-on" treatment for obesity, research being presented at the European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May) suggests.

19 May 2023

Regular exercise may decrease the risk of developing Parkinson's disease

Getting regular exercise such as cycling, walking, gardening, cleaning and participating in sports may decrease the risk of developing Parkinson's disease, according to new research published in the May 17, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 May 2023

High-fat diets can promote atherosclerosis via gut bacteria interactions with the immune system

In a recent study, researchers determined that derivatives of natural emulsifiers such as phospholipids found in high-fat, high-cholesterol diets can promote atherosclerosis via gut bacteria interactions with the immune system.

11 May 2023

Is medical cannabis treatment associated with improvements in health-related quality of life?

Researchers investigated whether cannabis treatment could improve the health-associated quality of life.

11 May 2023

Sleep apnea, lack of deep sleep associated with brain biomarkers of cerebrovascular disease

People who have sleep apnea and spend less time in deep sleep may be more likely to have brain biomarkers that have been linked to an increased risk of stroke, Alzheimer's disease and cognitive decline, according to new research published in the May 10, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 May 2023

Mount Sinai researchers identify a new therapeutic target for MS and other brain disorders

Cross-talk between brain cells and peripheral immune cells can modulate the progression of multiple sclerosis (MS), Mount Sinai researchers have discovered.

8 May 2023

Cancer-fighting immune cells can fuel their ability to attack tumors

When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that.

8 May 2023

NIH researchers gain new insights on rare immune deficiency

In an 11-year study, researchers at the National Institutes of Health have further characterized idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune diseases and cancers.

4 May 2023

Boxing could improve quality of life for Parkinson's patients

When we think of boxing, it's understandable many of us wouldn't associate it with being 'good' for our brains.

3 May 2023

Pregnancy's profound impact: How motherhood reshapes the female brain

Research discusses the impact of pregnancy on the brain, including its effects on neuroplasticity, neuroinflammation, and cognition. It also highlights the importance of studying female-specific factors in neuroscience research.

30 Apr 2023

Mount Sinai announces creation of the Institute for Regenerative Medicine

Regenerative medicine-; the process of replacing, engineering or regenerating human cells, tissues or organs-; holds exciting potential for the field of health care.

24 Apr 2023

Researchers develop a backpack-based myeloid cell therapy for MS patients

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ability to move and function to progressively decline.

21 Apr 2023

Research reveals a more effective treatment for multiple sclerosis patients

Degeneration of myelin, an insulating sheath required for rapid communication between nerve cells, and neuroinflammation are notable hallmarks of Multiple Sclerosis (MS) and related neurodegenerative disorders such as Alzheimer's disease or Huntington's disease that affect roughly 2.8 million people in the world.

21 Apr 2023

Neighborhood social factors may be linked to epilepsy outcomes

People with epilepsy living in disadvantaged neighborhoods-;areas with higher poverty levels and fewer educational and employment opportunities-; may be more likely to have memory, thinking, and mental health problems compared to people with epilepsy living in neighborhoods with fewer disadvantages, according to new research published in the April 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

20 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

New drug may offer relief for people with difficult-to-treat migraine

The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

20 Apr 2023

Simple memory test may identify people most likely to develop cognitive impairment

In people with no thinking and memory problems, a simple test may predict the risk of developing cognitive impairment years later, according to a study published in the April 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Apr 2023